Cancer BiologybioRxiv
Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities
M. R. Kelly, K. Kostyrko, K. Han…·P. K. Jackson
The paper identifies new RAS effector pathways and synthetic lethal interactions in lung adenocarcinoma using proteomic and genetic screening.
DOI 10.1158/2159-8290.cd-19-1274